Angiolillo DJ, Bernardo E, Sabaté M, Jiménez-Quevedo P, Costa MA, Palazuelos J, Hernández-Antolín R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Guzman LA, Bass TA, Macaya C, Fernández-Ortiz A
J. Am. Coll. Cardiol.. 2007 Oct;50(16):1541-7, PMID: 17936152
This study sought to determine the prognostic implications of high platelet reactivity (HPR) assessed in type 2 diabetes mellitus (T2DM) patients while in their steady-state phase of dual antiplatelet therapy.
CARDIAC & CARDIOVASCULAR SYSTEMS